Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Trevi Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1 – Newly Registered Securities | |||||||
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
Equity | Common Stock, $0.001 par value per share | Other (2) | 2,631,938 (3) | $2.97 (2) | $7,816,855.86 | .0001102 | $861.42 |
Total Offering Amounts | – | $7,816,855.86 | – | $861.42 | |||
Total Fee Offsets | – | – | – | – | |||
Net Fee Due | – | – | – | $861.42 | |||
|
(1) | Pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of the Registrant’s common stock, $0.001 par value per share (“Common Stock”), that may from time to time be offered or issued to prevent dilution by reason of any stock dividend, stock split or other similar transaction. |
(2) | The proposed maximum offering price per unit of $2.97 is estimated pursuant to Rule 457(c) and Rule 457(h) of the Securities Act solely for purposes of calculating the registration fee, and is based upon the average of the high and low prices of the Common Stock on May 10, 2023, as reported on the Nasdaq Global Market. |
(3) | Consists of (i) 2,105,623 additional shares issuable under the Trevi Therapeutics, Inc. 2019 Stock Incentive Plan, and (ii) 526,315 additional shares issuable under the Trevi Therapeutics, Inc. 2019 Employee Stock Purchase Plan. |
